Clinical Trial Update: The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA)

View source ↗

Summary

This entry notes the completion of AstraZeneca's PRISMA trial evaluating the prevalence of systemic lupus erythematosus in Russian patients with reproductive is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: AstraZeneca | Conditions: Systemic Lupus Erythematosus | Status: COMPLETED